Pfizer continues to drop since 6/9. The volume is slightly below average.

I had a hard time drawing the next level of support and had to go back to the monthly.

I am thinking of adding to my position here.

Stat	Value
PE	12.03
EPS	2.80
Beta	0.97
Profit Margin	31.17%
Operating Margin	29.36%
Avg Volume	30.28M
Shares Outstanding	5.55B
Float	5.55B
Shares Short	52.04M
Short % of Outstanding	0.94%
Dividend	4.56%

Ex-Dividend May 07, 2020
% Held by Insiders | 0.04%
% Held by Institutions | 72.56%

Positives:

• Below Fair Value: PFE ($33.3) is trading below our estimate of fair value ($70.72)
• Significantly Below Fair Value: PFE is trading below fair value by more than 20%.*
• Short Term Liabilities: PFE's short term assets ($34.7B) exceed its short term liabilities ($33.9B).
• Debt Coverage: PFE's debt is well covered by operating cash flow (27.5%).
• Interest Coverage: PFE's interest payments on its debt are well covered by EBIT (12.6x coverage).

Negatives

• Long Term Liabilities: PFE's short term assets ($34.7B) do not cover its long term liabilities ($67.1B).
• Debt Level: PFE's debt to equity ratio (78%) is considered high.
• Reducing Debt: PFE's debt to equity ratio has increased from 53.3% to 78% over the past 5 years.